NL
REGN icon

NVWM LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

NVWM LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.9K Hold
128
– – 0.02% 219
2025
Q4 		$98.8K Buy
128
+122
+2,033% +$82.9K 0.02% 215
2025
Q3 		$3.37K Hold
6
– – ﹤0.01% 371
2025
Q2 		$3.15K Hold
6
– – ﹤0.01% 371
2025
Q1 		$3.81K Buy
6
+3
+100% +$2.06K ﹤0.01% 336
2024
Q4 		$2.14K Sell
3
-985
-100% -$827K ﹤0.01% 371
2024
Q3 		$1.04M Buy
988
+14
+1% +$15.6K 0.26% 122
2024
Q2 		$1.02M Sell
974
-5
-0.5% -$4.85K 0.27% 114
2024
Q1 		$942K Buy
979
+84
+9% +$79.9K 0.26% 124
2023
Q4 		$786K Buy
+895
New +$737K 0.24% 134
2023
Q2 		– Sell
-13
Closed -$10.7K – 478
2023
Q1 		$10.7K Hold
13
– – ﹤0.01% 337
2022
Q4 		$9.38K Hold
13
– – ﹤0.01% 327
2022
Q3 		$9K Hold
13
– – ﹤0.01% 336
2022
Q2 		$8K Hold
13
– – ﹤0.01% 363
2022
Q1 		$9K Hold
13
– – ﹤0.01% 389
2021
Q4 		$8K Buy
13
+6
+86% +$3.69K ﹤0.01% 411
2021
Q3 		$4K Buy
+7
New +$4.35K ﹤0.01% 440
2020
Q4 		– Sell
-1,064
Closed -$596K – 426
2020
Q3 		$596K Buy
1,064
+43
+4% +$26.1K 0.28% 110
2020
Q2 		$637K Buy
1,021
+2
+0.2% +$1.14K 0.34% 91
2020
Q1 		$498K Buy
+1,019
New +$420K 0.35% 84
2019
Q2 		– Sell
-1,052
Closed -$432K – 382
2019
Q1 		$432K Buy
+1,052
New +$433K 0.29% 115

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

NVWM LLC's REGN Position: Q1 2026 in Review

NVWM LLC held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 128 shares worth $98.9K. The position accounts for 0.02% of the portfolio, ranked #219.

NVWM LLC first reported a position in REGN in Q1 2019 and has held it in 21 quarters since. The position peaked at $1.04M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • NVWM LLC held 128 shares of Regeneron Pharmaceuticals worth $98.9K as of Q1 2026.
  • NVWM LLC left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.02% of NVWM LLC's portfolio in Q1 2026, its #219 holding.
  • NVWM LLC first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 21 quarters since.
  • NVWM LLC's Regeneron Pharmaceuticals position peaked at $1.04M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.